94 related articles for article (PubMed ID: 10465134)
1. A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.
Tognoni A; Cadenotti L; Pensa F; Vaira F; Vigani A; Bancalari L; Cordani S; Maggiani R; Canessa PA; Pronzato P
J Chemother; 1999 Aug; 11(4):306-9. PubMed ID: 10465134
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
3. A pilot study with cisplatin, ifosfamide and weekly administration of vinorelbine as an outpatient combination chemotherapy for advanced non small cell lung cancer.
Tibaldi C; Baldini E; Ricci S; Conte PF
Anticancer Res; 1996; 16(5B):3213-5. PubMed ID: 8920792
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
Baldini E; Tibaldi C; Chella A; Angeletti CA; Romanini A; Andrei A; Algeri R; Silvano G; Conte PF
Semin Oncol; 1994 Jun; 21(3 Suppl 4):12-5. PubMed ID: 8209271
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
7. Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
Drinkard LC; Hoffman PC; Samuels BL; Watson S; Bitran JD; Golomb HM; Vokes EE
Semin Oncol; 1995 Apr; 22(2 Suppl 5):30-7; discussion 41-4. PubMed ID: 7537911
[TBL] [Abstract][Full Text] [Related]
8. A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
Masters GA; Hoffman PC; Drinkard LC; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1998 Feb; 25(1 Suppl 2):8-14. PubMed ID: 9535205
[TBL] [Abstract][Full Text] [Related]
9. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
Masters GA; Mauer AM; Hoffman PC; Wyka D; Samuels BL; Krauss SA; Watson S; Golomb H; Vokes EE
Ann Oncol; 1998 Jun; 9(6):677-80. PubMed ID: 9681085
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
Fujita A; Takabatake H; Tagaki S; Sekine K
Cancer Chemother Pharmacol; 2000; 45(4):279-83. PubMed ID: 10755315
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
Rey F; Astoul P; Marqueste L; Petite JM; Boutin C; Viallat JR
Am J Clin Oncol; 1998 Oct; 21(5):518-22. PubMed ID: 9781613
[TBL] [Abstract][Full Text] [Related]
12. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
Graziano SL; Valone FH; Herndon JE; Crawford J; Richards F; Rege VB; Clamon G; Green MR
Lung Cancer; 1996 Jun; 14(2-3):315-29. PubMed ID: 8794413
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
Masters GA; Hoffman PC; Hsieh A; Drinkard LC; Mick R; Samuels BL; Guaspari A; Golomb HM; Vokes EE
J Clin Oncol; 1997 Mar; 15(3):884-92. PubMed ID: 9060524
[TBL] [Abstract][Full Text] [Related]
15. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
Crawford J; O'Rourke MA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
[TBL] [Abstract][Full Text] [Related]
16. A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
Levitan N; Dowlati A; Craffey M; Tahsildar H; MacKay W; McKenney J; Remick SC
Lung Cancer; 1998 Dec; 22(3):227-34. PubMed ID: 10048475
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
Gottfried M; Ramlau R; Krzakowski M; Ziolo G; Olechnowicz H; Koubkova L; Dahabreh J; Szczesna A; Vivanco GL; Perng RP; Carpagnano F; Leong SS; Fittipaldo A; De Almeida C; Aubert D; Grunenwald D
J Thorac Oncol; 2008 Feb; 3(2):152-7. PubMed ID: 18303436
[TBL] [Abstract][Full Text] [Related]
19. Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
Ahn JB; Ko WK; Lee JG; Shim KY; Jeung HC; Park JO; Yoo NC; Kim BS; Kim SK; Kim SK; Kim JH
Am J Clin Oncol; 2000 Dec; 23(6):622-8. PubMed ID: 11202811
[TBL] [Abstract][Full Text] [Related]
20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]